IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 3, Issue 3 (2022)
J Clinic Care Skill 2022, 3(3): 119-124 |
Back to browse issues page
Article Type:
History
Received: 2022/07/12 | Accepted: 2022/09/19 | Published: 2022/09/19
Received: 2022/07/12 | Accepted: 2022/09/19 | Published: 2022/09/19
How to cite this article
Shahamat M. Characteristics of COVID-19 Infection in Paediatric Patients:
A Narrative Review. J Clinic Care Skill 2022; 3 (3) :119-124
URL: http://jccs.yums.ac.ir/article-1-145-en.html
URL: http://jccs.yums.ac.ir/article-1-145-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
M. Shahamat * 
Department of Pediatrics, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract (1417 Views)
Aims: The COVID-19 pandemic has been a global crisis for more than two years, which caused an immense global burden on economy, health care and education. More than 250 million people have been infected with this novel virus, among which more than 5 million have died. Prevention is the best strategy against COVID-19 infection in both children and adults. This narrative review aimed at summarizing the important epidemiological and clinical findings of COVID-19 infection and its transmission, clinical manifestation, laboratory findings, radiographic findings, and diagnosis.
Conclusion: Reports have shown that paediatric patients are often exposed to the SARS-CoV-2 virus through a family member, and that COVID-19 infection is a serious threat to this vulnerable age group. Milder or asymptomatic manifestations of this new disease in younger patients should not cause this population to be neglected. Numerous epidemiological and clinical studies have reported the burden of this novel infection in children and the chance of severe forms of infection, hospitalisation, and admission to ICU. However, many aspects of pathophysiological and immunological mechanisms regarding COVID-19 infection in children are still unexplained. Clinical characteristics of COVID-19 infection is different in children compared to adults, and a comprehensive knowledge regarding this distinction can lead to timely diagnosis and successful management of COVID-19 in these patients.
Conclusion: Reports have shown that paediatric patients are often exposed to the SARS-CoV-2 virus through a family member, and that COVID-19 infection is a serious threat to this vulnerable age group. Milder or asymptomatic manifestations of this new disease in younger patients should not cause this population to be neglected. Numerous epidemiological and clinical studies have reported the burden of this novel infection in children and the chance of severe forms of infection, hospitalisation, and admission to ICU. However, many aspects of pathophysiological and immunological mechanisms regarding COVID-19 infection in children are still unexplained. Clinical characteristics of COVID-19 infection is different in children compared to adults, and a comprehensive knowledge regarding this distinction can lead to timely diagnosis and successful management of COVID-19 in these patients.
Keywords:
COVID-19 [MeSH], SARS-COV-2 [MeSH], Pediatrics [MeSH], Patients [MeSH], Diagnosis [MeSH], Clinical Manifestation [MeSH], Transmission [MeSH]
References
1. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135. [DOI:10.3390/v12020135] [PMID] [PMCID]
2. Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]
3. Deng S-Q, Peng H-J. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9(2):575. [DOI:10.3390/jcm9020575] [PMID] [PMCID]
4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID]
5. Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, et al. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol. 2020;883:173375. [DOI:10.1016/j.ejphar.2020.173375] [PMID] [PMCID]
6. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, et al. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. 2020;92(6):584-8. [DOI:10.1002/jmv.25719] [PMID] [PMCID]
7. Shang J, Wan Y, Liu C, Yount B, Gully K, et al. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog. 2020;16(3):e1008392. [DOI:10.1371/journal.ppat.1008392] [PMID] [PMCID]
8. Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, et al. Immune-mediated approaches against COVID-19. Nat Nanotechnol. 2020;15(8):630-45. [DOI:10.1038/s41565-020-0732-3] [PMID] [PMCID]
9. Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, et al. A comprehensive review of COVID-19 characteristics. Biol Proced Online. 2020;22:19. [DOI:10.1186/s12575-020-00128-2] [PMID] [PMCID]
10. Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, et al. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One. 2021;16(3):e0247461. [DOI:10.1371/journal.pone.0247461] [PMID] [PMCID]
11. Ko JY, Danielson ML, Town M, Derado G, Greenlund KJ, et al. Risk factors for Coronavirus Disease 2019 (COVID-19)-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system. Clin Infect Dis. 2021;72(11):e695-703. [DOI:10.1101/2020.07.27.20161810]
12. Kalantari H, Tabrizi AHH, Foroohi F. Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Rep. 2020;21:100910. [DOI:10.1016/j.genrep.2020.100910] [PMID] [PMCID]
13. Bi Q, Wu Y, Mei S, Ye C, Zou X, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-9. [DOI:10.1016/S1473-3099(20)30287-5]
14. Bauer P, Brugger J, König F, Posch M. An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis. Sci Rep. 2021;11(1):19143. [DOI:10.1038/s41598-021-97711-8] [PMID] [PMCID]
15. Shi Q, Wang Z, Liu J, Wang X, Zhou Q, et al. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021;41:101155. [DOI:10.1016/j.eclinm.2021.101155] [PMID] [PMCID]
16. Dong Y, Mo X, Hu Y, Qi X, Jiang F, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. [DOI:10.1542/peds.2020-0702] [PMID]
17. Rankin DA, Talj R, Howard LM, Halasa NB. Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States. Curr Opin Pediatr. 2021;33(1):114-21. [DOI:10.1097/MOP.0000000000000971] [PMID] [PMCID]
18. She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol. 2020;92(7):747-54. [DOI:10.1002/jmv.25807] [PMID] [PMCID]
19. Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207. [DOI:10.1056/NEJMoa2001316] [PMID] [PMCID]
20. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;71(6):1547-51. [DOI:10.1093/cid/ciaa198] [PMID] [PMCID]
21. Shen K-L, Yang Y-H, Jiang R-M, Wang T-Y, Zhao D-C, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition). World J Pediatr. 2020;16(3):232-9. [DOI:10.1007/s12519-020-00362-4] [PMID] [PMCID]
22. Zou L, Ruan F, Huang M, Liang L, Huang H, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-9. [DOI:10.1056/NEJMc2001737] [PMID] [PMCID]
23. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, et al. Author correction: Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;588(7839):E35. [DOI:10.1038/s41586-020-2984-3] [PMID]
24. Jones TC, Mühlemann B, Veith T, Biele G, Zuchowski M, et al. An analysis of SARS-CoV-2 viral load by patient age. Med Rxiv. 2020. [DOI:10.1101/2020.06.08.20125484]
25. Lee B, Raszka WV. COVID-19 transmission and children: The child is not to blame. Pediatrics. 2020;146(2):e2020004879. [DOI:10.1542/peds.2020-004879] [PMID]
26. Woodworth KR, Moulia D, Collins JP, Hadler SC, Jones JM, et al. The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years-United States, November 2021. MMWR Morb Mortal Wkly Rep. 2021;70(45):1579-83. [DOI:10.15585/mmwr.mm7045e1] [PMID] [PMCID]
27. Qiu H, Wu J, Hong L, Luo Y, Song Q, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689-96. [DOI:10.1016/S1473-3099(20)30198-5]
28. Ismail SA, Saliba V, Lopez Bernal J, Ramsay ME, Ladhani SN. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect Dis. 2021;21(3):344-53. [DOI:10.1016/S1473-3099(20)30882-3]
29. Han X, Li X, Xiao Y, Yang R, Wang Y, et al. Distinct characteristics of COVID-19 infection in children. Front Pediatr. 2021;9:619738. [DOI:10.3389/fped.2021.619738] [PMID] [PMCID]
30. Xu Y, Li X, Zhu B, Liang H, Fang C, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502-5. [DOI:10.1038/s41591-020-0817-4] [PMID] [PMCID]
31. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51. [DOI:10.1111/apt.15731] [PMID] [PMCID]
32. Zhu Z, Liu Y, Xu L, Guan W, Zhang X, et al. Extra-pulmonary viral shedding in H7N9 Avian Influenza patients. J Clin Virol. 2015;69 30-2. [DOI:10.1016/j.jcv.2015.05.013] [PMID]
33. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. [DOI:10.1111/apa.15270] [PMID] [PMCID]
34. See K, Liew SM, Ng DC, Chew E, Khoo EM, et al.
35. COVID-19: four paediatric cases in Malaysia. Int J Infect Dis. 2020;94 125-7. [DOI:10.1016/j.ijid.2020.03.049] [PMID] [PMCID]
36. Chen J, Qi T, Liu L, Ling Y, Qian Z, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):e1-6. [DOI:10.1016/j.jinf.2020.03.004] [PMID] [PMCID]
37. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-23. [DOI:10.1016/S0140-6736(20)30154-9]
38. Zeng L, Tao X, Yuan W, Wang J, Liu X, et al. First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. Chin J Pediatr. 2020;58(0):E009. [Chinese]
39. Chen N, Zhou M, Dong X, Qu J, Gong F, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. [DOI:10.1016/S0140-6736(20)30211-7]
40. Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
41. Chen F, Liu Z, Zhang F, Xiong R, Chen Y, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. Chin J Pediatr. 2020;58(3):179-82. [Chinese]
42. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8. [DOI:10.1016/S0140-6736(20)31103-X]
43. Ferdosian F, Samadzadeh G, Nafei Z. Kawasaki-Like Disease in Children during COVID-19 Pandemic: Two Case Reports. Int J Pediatr. 2021;9(10):14624-9.
44. Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020;25(22):2001010. [DOI:10.2807/1560-7917.ES.2020.25.22.2001010] [PMID] [PMCID]
45. Gagliardi L, Bertacca C, Centenari C, Merusi I, Parolo E, et al. Orchiepididymitis in a boy with COVID-19. Pediatr Infect Dis J. 2020;39(8):e200-2. [DOI:10.1097/INF.0000000000002769] [PMID]
46. Zhang Z, Guo L, Huang L, Zhang C, Luo R, et al. Distinct disease severity between children and older adults with Coronavirus Disease 2019 (COVID-19): Impacts of ACE2 expression, distribution, and lung progenitor cells. Clin Infect Dis. 2021;73(11):e4154-65. [DOI:10.1093/cid/ciaa1911] [PMID] [PMCID]
47. Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. [DOI:10.1016/S0140-6736(20)30251-8]
48. Quantius J, Schmoldt C, Vazquez-Armendariz AI, Becker C, El Agha E, et al. Influenza virus infects epithelial stem/progenitor cells of the distal lung: Impact on Fgfr2b-Driven epithelial repair. PLOS Pathog. 2016;12(6):e1005544. [DOI:10.1371/journal.ppat.1005544] [PMID] [PMCID]
49. Chen Y, Chan V S, Zheng B, Chan K Y, Xu X, et al. A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med. 2007;204(11):2529-36. [DOI:10.1084/jem.20070462] [PMID] [PMCID]
50. Dhochak N, Singhal T, Kabra SK, Lodha R. Pathophysiology of COVID-19: Why children fare better than adults? Indian J Pediatr. 2020;87(7):537-46. [DOI:10.1007/s12098-020-03322-y] [PMID] [PMCID]
51. GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191-210.
52. Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52 Suppl 1:S75-82. [DOI:10.1093/cid/ciq012] [PMID]
53. Qin C, Zhou L, Hu Z, Zhang S, Yang S, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8. [DOI:10.1093/cid/ciaa248] [PMID] [PMCID]
54. Wang X F, Yuan J, Zheng Y J, Chen J, Bao Y M, et al. Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Zhonghua Er Ke Za Zhi. 2020;58(0):E008. [Chinese]
55. Tan Y-P, Tan B-Y, Pan J, Wu J, Zeng S-Z, et al. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China. J Clin Virol. 2020;127:104353. [DOI:10.1016/j.jcv.2020.104353] [PMID] [PMCID]
56. Fahimzad A, Sedighi I, Pak N, Khalili M, Farahmand M, et al. A comparative analysis of clinical characteristics and laboratory findings of COVID-19 between intensive care unit and non-intensive care Unit pediatric patients: A multicenter, retrospective, observational study from Iranian network for research in viral. Front Med. 2021;5(4):e41. [DOI:10.18502/fem.v5i4.6692]
57. Bouadma L, Lescure F-X, Lucet J-C, Yazdanpanah Y, Timsit J-F. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46(4):579-82. [DOI:10.1007/s00134-020-05967-x] [PMID] [PMCID]
58. Liu P, Cai J, Jia R, Xia S, Wang X, et al. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19. Emerg Microbes Infect. 2020;9(1):1254-8. [DOI:10.1080/22221751.2020.1772677] [PMID] [PMCID]
59. Kumar J, Meena J, Yadav A, Yadav J. Radiological findings of COVID-19 in children: a systematic review and meta-analysis. J Trop Pediatr. 2021;67(3):fmaa045. [DOI:10.1093/tropej/fmaa045] [PMID] [PMCID]
60. Duan Y-N, Zhu Y-Q, Tang L-L, Qin J. CT features of novel coronavirus pneumonia (COVID-19) in children. Eur Radiol. 2020;30(8):4427-33. [DOI:10.1007/s00330-020-06860-3] [PMID] [PMCID]
61. Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: expert recommendation from the Chinese Society of Radiology. Chin J Radiol. 2020;4(54):279-85. [Chinese]
62. Carlotti A, Carvalho WB, Johnston C, Rodriguez IS, Delgado AF. COVID-19 diagnostic and management protocol for pediatric patients. Clinics (Sao Paulo). 2020;75:e1894. [DOI:10.6061/clinics/2020/e1894] [PMID] [PMCID]